New Delhi, March 27 -- The Indian Pharmacopoeia Commission (IPC), a body under the health ministry, has named five lifesaving drugs as having shown serious side effects.

The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics drug Gliclazide and Tramadol, a painkiller.

During a recently conducted analysis of adverse drug reactions (ADRs), the commission found that the use of these drugs can cause severe reactions, including muscle spasms.

The government body has asked the and patients to report any adverse events associated with the use of the drugs to the authorities.

Also read | India to offer drug regulatory training to Africa, Saarc nations

"The analysis of adverse...